Rapport Therapeutics Inc. (RAPP)
NASDAQ: RAPPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 30.86 0.00%
RAPP stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.48B
- EPS (TTM)
- -$3.03
- Dividend yield
- None
- 52-week range
- 23.75 – 52.93
- Day range
- 30.46 – 31.35
- Volume / Avg
- 314.91K / 370.01K
- Beta
- —
- Shares outstanding
- 47.98M
- Next earnings
- Nov 5, 2026
52-week range
RAPP stock today
On Oct 7, RAPP ended the session at $30.86, shedding $0.29 (0.93%), versus the S&P 500's 0.22% decline. Shares are 41.7% below their 52-week high of $52.93, set on Aug 27, 2026 and 29.9% above the 52-week low of $23.75, in the middle of the past year's range. RAPP is up 1.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 16.7%.
Rapport Therapeutics has posted a net loss over the last twelve months (EPS of -$3.03), so its P/E ratio is not meaningful. Rapport Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Rapport Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2024
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-1.21
RAPP news
All RAPP newsRapport Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SNDXSyndax Pharmaceuticals Inc. | 17.03 | -1.96% | $1.52B | vs RAPP |
| RAREUltragenyx Pharmaceutical Inc. | 14.89 | +2.97% | $1.47B | vs RAPP |
| INVAInnoviva Inc. | 21.06 | +1.10% | $1.52B | vs RAPP |
| PAHCPhibro Animal Health Corporation Class A | 37.72 | +3.03% | $1.53B | vs RAPP |
| GHRSGH Research PLC | 21.06 | -2.14% | $1.45B | vs RAPP |
| KRSAKorsana Biosciences Inc. | 31.65 | -0.38% | $1.44B | vs RAPP |
| STOKStoke Therapeutics Inc. | 24.29 | -0.33% | $1.57B | vs RAPP |
| ETONEton Pharmaceuticals Inc. | 54.88 | +0.20% | $1.57B | vs RAPP |
Indexes, lists and sector
Rapport Therapeutics stock FAQ
What is Rapport Therapeutics's stock price today?
RAPP last traded at $30.86 as of Oct 7, 4:00 PM EDT, down 0.93% on the day. Prices are delayed at least 15 minutes.
When is Rapport Therapeutics's next earnings date?
Rapport Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-1.21.
What is the RAPP 52-week high?
The 52-week high for RAPP is $52.93 and the 52-week low is $23.75. The stock is currently 41.7% below its high.